Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,559 Cr₹871 Cr₹1,075 Cr₹671 Cr₹602 Cr

What is the latest Sundry Debtors ratio of GLAND PHARMA ?

The latest Sundry Debtors ratio of GLAND PHARMA is ₹1,559 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,559 Cr
Mar2023₹871 Cr
Mar2022₹1,075 Cr
Mar2021₹671 Cr
Mar2020₹602 Cr

How is Sundry Debtors of GLAND PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,559 Cr
78.87
Mar2023 ₹871 Cr
-18.93
Mar2022 ₹1,075 Cr
60.19
Mar2021 ₹671 Cr
11.50
Mar2020 ₹602 Cr -

Compare Sundry Debtors of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,124.1 Cr 0.1% 11.8% -6.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹119,919.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -2.6% -8.1% -4.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.1%

11.8%

-6.3%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses